Haoxi Health Technology Limited (HAO)
0.103
-0.001 (-1.05%)
Inactive · Last trade price on Jan 24, 2025

Haoxi Health Technology Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jun '24 Jun '23 Jun '22 Jun '21
Net Income
1.290.970.240.3
Depreciation & Amortization
0.010.0100
Loss (Gain) From Sale of Assets
---0.01
Other Operating Activities
---0.18
Change in Accounts Receivable
-0.22-00.67-0.3
Change in Accounts Payable
0.62-1.2-1.62.71
Change in Unearned Revenue
---0.43
Change in Income Taxes
0.710.33-0.030.03
Change in Other Net Operating Assets
-3.16-0.980.05-0.72
Operating Cash Flow
-0.75-0.87-0.682.65
Capital Expenditures
-0.06-0.05-0.01-0
Investing Cash Flow
-3.13-0.05-0.01-0
Short-Term Debt Issued
0.480.470.330.16
Long-Term Debt Issued
-0.26--
Total Debt Issued
0.480.730.330.16
Short-Term Debt Repaid
-0.13-0.35-0.86-1.5
Total Debt Repaid
-0.13-0.35-0.86-1.5
Net Debt Issued (Repaid)
0.350.39-0.53-1.34
Issuance of Common Stock
8.981.990.16-
Other Financing Activities
--0.581.3-1.27
Financing Cash Flow
9.321.80.93-2.61
Foreign Exchange Rate Adjustments
0.010.02-0.010
Miscellaneous Cash Flow Adjustments
---0-
Net Cash Flow
5.450.910.240.04
Free Cash Flow
-0.8-0.92-0.682.65
Free Cash Flow Margin
-1.65%-3.25%-4.23%20.59%
Free Cash Flow Per Share
-0.03-0.03-0.030.11
Cash Interest Paid
0.040.0200.01
Cash Income Tax Paid
0.03-0.010
Levered Free Cash Flow
-4.17-1.29-0.34-
Unlevered Free Cash Flow
-4.14-1.28-0.33-
Change in Net Working Capital
5.171.990.49-
Source: S&P Capital IQ. Standard template. Financial Sources.